logo
Plus   Neg
Share
Email

Myriad Genetics Inc. Q4 adjusted earnings Beat Estimates

Below are the earnings highlights for Myriad Genetics Inc. (MYGN):

-Earnings: -$55.4 million in Q4 vs. -$4.2 million in the same period last year.
-EPS: -$0.74 in Q4 vs. -$0.06 in the same period last year.
-Excluding items, Myriad Genetics Inc. reported adjusted earnings of -$23.4 million or -$0.31 per share for the period.
-Analysts projected -$0.47 per share
-Revenue: $93.2 million in Q4 vs. $215.4 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT